In a future post, I will detail Amgen's spend, as well as Pfizer's -- and for the first time, perhaps. . . Amazon's (with only a bit of it, as a footnote today, bottom of this post).
Here is a partial run down of what Merck itself says it lobbied about in Q1 2022:
. . .H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act; H.R. 19 Lower Costs, More Cures Act of 2021; H.R. 1550, PREVENT HPV Cancers Act of 2021; H.R. 2873, Affordable Prescriptions for Patients Through Promoting Competition Act of 2021; H.R. 3173, Improving Seniors Timely Access to Care Act of 2021; H.R. 3932/S. 2079, Pioneering Antimicrobial Subscriptions To End Up surging Resistance (PASTEUR) Act of 2021; H.R. 4127, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2021; H.R. 5260, Reduced Costs and Continued Cures Act; H.R. 5376, Build Back Better Act; H.R. 5416, Give Kids a Chance Act; H.R. 5801, Help Ensure Lower Patient (HELP) Copays Act; H.R. 6584, Diverse and Equitable Participation in Clinical Trials (DEPICT) Act; H.R. 6963, Accelerated Approval Integrity Act of 2022; H.R. 7559, Prescription Information Modernization Act of 2022; H.R. 7667, Food and Drug Amendments of 2022; S. 1435, Affordable Prescriptions for Patients Act of 2021; S. 1712, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; S. 2774, Pride in Patent Ownership Act; S. 2891, Restoring the America Invents Act; S. 2543 (116th Congress) Prescription Drug Pricing Reduction Act of 2019; S. 1895 (116th Congress) Lower Health Care Costs Act; S. 4348, Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022. . . .
Issues relating to 340B program integrity; 340B of the Public Health Services Act; 340B policy; 340B issues; 340B drug pricing program; Drug pricing; Drug Pricing reforms - international reference prices and government price setting; Anti-microbial Resistance; Vaccines; COVID-19 vaccines; COVID-19 therapeutics coverage issues; COVID-19 Pandemic response; Cost and value of medicines; Respiratory Syncytial Virus (RSV) immunization; Vaccines catch up; Vaccine provisions; Vaccine Issues, including return to care access, and pandemic-related policy; Package inserts, labeling issues, and E-Labeling authorization legislation; Pharmaceutical Supply Channel Isssues; Prescription Drug User Fees Act (P.L. 102-571); Prescription drug cost-sharing; Accelerated approval reform; Food and Drug Administration Safety and Landmark Advancements (FDASLA); Executive Order 13937, Access to Affordable Life-Saving Medications; FY-2023 Budget and Appropriations Legislation; Intellectual property protection; WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; Animal Health; Animal Health Technology Issues; One Health Issues; Rural Broadband Issues; General pharmaceutical issues; Farm Bill 2023; Animal Drug User Fee Act 2023. . . .
As a footnote, I did want to mention that in addition to lobbying in favor of broader cannabis legalization, Amazon lobbied for quite a bit of direct health care / life sciences measures: "Issues related to health care, including employee health care plans, HIPAA, health information technology, telehealth, including the Consolidated Appropriations Act, 2022 (Public Law 117-103), the Telehealth Modernization Act (H.R. 1332 / S. 368), the CONNECT Act (H.R. 2903 / S. 1512), the Telehealth Expansion Act (S. 1704), and the Ensuring Telehealth Expansion Act (H.R. 341), the Cures 2.0 Act (H.R. 6000), and the Food and Drug Amendments Act of 2023 (H.R. 7667), the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S. 4348), and the Prescription Information Modernization Act of 2022 (H.R. 7559). Issues related to pharmacy, vaccines, and COVID-19 testing, including implementation of the CARES Act (Public Law 116-136). . . ."
Now you know. . . grinning, with baby girls sleeping over, tonight -- and youngest grown son home by early Monday morning. Blog-forecast: spotty to intermittent, next week. Smile.
नमस्ते
No comments:
Post a Comment